October 7, 2020

Vineti at Cell and Gene Meeting on the Mesa 2020

Next week marks the start of a very important annual event in advanced therapies — the Alliance for Regenerative Medicine’s annual Cell and Gene Meeting on the Mesa. The gathering is a rare opportunity for decision makers in advanced therapies to catch up, share progress, and make new connections. And this year, like so many other events, it’s happening in a whole new way.

This year’s “Mesa” will be entirely virtual. Vineti completely supports that decision amid the ongoing threat from COVID-19. And yet we also wanted to take a minute to acknowledge what we’ll all miss — the chance for serendipitous connections and collaborations that Mesa so often provides. We hope to see as many of you as possible in virtual Mesa next week!

We also wanted to announce two upcoming presentations that we’ll be making at Mesa 2020:  

  • Our CEO and Co-founder, Amy DuRoss, will give a Company Presentation. Company presentations will be available to view on-demand throughout the entirety of the conference.
  • Amy is also speaking on the panel “The Lasting COVID-19 Impact on Cell and Gene Therapy” on Wednesday, October 14 at 12 noon PT/3pm ET.  

If you are already registered and would like to speak with our team, please find us through the PartneringONE system, or email us at You can also find us at our Mesa virtual booth, where an industry mini-survey organized with our vein-to-vein network partners

Lonza and Cryoport will be available. 

The first 15 respondents will win an Amazon gift card! 
Organized by the Alliance for Regenerative Medicine, the Cell & Gene Meeting on the Mesa is a five-day virtual conference featuring more than 120 dedicated company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies. The meeting also includes more than 100 panelists and featured speakers taking part in 20 in-depth sessions covering all aspects of cell and gene therapy commercialization.

Please visit for full information, including registration. We look forward to seeing you online — and seeing you all in person at a future Mesa.

Vineti provides the leading digital platform of record for personalized therapeutics, such as CAR-T cell therapies. If you’d like to learn more about how Vineti’s Personalized Therapy Management Platform® (PTM) is simplifying, standardizing, and industrializing workflows for personalized therapies, please contact us.